Related Experiment Video
Updated: Jul 10, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis
Nicholas C K Heng1, Grace A Burtenshaw, Ralph W Jack
1Department of Microbiology and Immunology, University of Otago, P.O. Box 56, Dunedin 9054, New Zealand. nicholas.heng@stonebow.otago.ac.nz
Streptococcus uberis causes bovine mastitis and produces ubericin A, a novel bacteriocin. This study details the purification and characterization of ubericin A and its genetic locus.
Area of Science:
- Microbiology
- Bacteriocins
- Animal Health
Background:
- Streptococcus uberis is a significant pathogen causing bovine mastitis.
- Bacteriocins are antimicrobial peptides with potential therapeutic applications.
- Class IIa bacteriocins, like pediocin, are well-studied, but streptococcal examples are less characterized.
Purpose of the Study:
- To purify and characterize ubericin A, a bacteriocin produced by Streptococcus uberis.
- To identify and describe the genetic locus responsible for ubericin A production and immunity.
Main Methods:
- Purification of ubericin A from Streptococcus uberis.
- Biochemical and functional characterization of the purified bacteriocin.
- Genetic analysis of the uba locus, including sequencing and gene identification.
Main Results:
- Ubericin A was purified as a 5.3-kDa peptide.
- The uba locus contains two overlapping genes: ubaA (precursor peptide) and ubaI (immunity protein).
- Ubericin A represents the first characterized class IIa bacteriocin from a streptococcal species.
Conclusions:
- Ubericin A is a novel class IIa bacteriocin produced by Streptococcus uberis.
- The identified genetic locus provides insights into the biosynthesis and regulation of this bacteriocin.
- This discovery expands the known diversity of bacteriocins and their producers.
Related Concept Videos
Regulation of Bacterial Virulence
Inhibitors of Bacterial Protein Synthesis
Antibiotic Selection
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial Phylum Verrucomicrobiota
Staphylococcal Skin Infections

